SERS nanoparticles: a new optical detection modality for cancer diagnosis.

Nanomedicine (Lond)

Oxonica Inc, 665 Clyde Avenue, Suite A, Mountain View, CA 94043, USA.

Published: October 2007

Surface-enhanced Raman scattering (SERS) is an optical detection technique that offers advantages over traditional assay detection technologies, such as fluorescence and chemiluminescence. These advantages include sensitivity, high levels of multiplexing, robustness and ability to perform detection in blood and other biological matrices. Here, we report on the growing field of SERS-active nanoparticles as a novel method for detection, with special emphasis on their use in the field of oncology. We discuss examples of SERS-active nanoparticles used in an assay for PSA, BRCA1 and Her-2, along with examples of nucleic-acid detection. We present data on a novel homogeneous, single-tube, rapid assay for nucleic acid detection and show how it will benefit the oncology community.

Download full-text PDF

Source
http://dx.doi.org/10.2217/17435889.2.5.725DOI Listing

Publication Analysis

Top Keywords

optical detection
8
sers-active nanoparticles
8
detection
7
sers nanoparticles
4
nanoparticles optical
4
detection modality
4
modality cancer
4
cancer diagnosis
4
diagnosis surface-enhanced
4
surface-enhanced raman
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!